Antibody-Mediated Red Blood Cell Destruction: Agglutination and Hemolytic Anemia

When antibodies bind to antigens on red blood cells (RBCs), they cause agglutination (clumping) and can trigger hemolysis (RBC destruction), leading to hemolytic anemia.

Mechanism

  1. Antigen-antibody binding: IgG or IgM binds specific RBC surface antigens (ABO, Rh, Kell, Duffy, Kidd, etc.).
  2. Agglutination: IgM (pentamer) directly cross-links RBCs; IgG requires secondary mechanisms (complement, Fc receptor-mediated).
  3. Hemolysis pathways:
    • Intravascular: Complement (C5b-9) membrane attack complex → RBC lysis in circulation → hemoglobinemia, hemoglobinuria.
    • Extravascular: IgG-opsonized RBCs cleared by splenic/liver macrophages → bilirubin ↑, LDH ↑, haptoglobin ↓.

Types of Immune Hemolytic Anemia

Autoimmune Hemolytic Anemia (AIHA)

  • Warm AIHA (IgG): Most common; idiopathic or secondary (SLE, CLL, drugs).
  • Cold agglutinin disease (IgM): Cold-induced agglutination; complement-mediated.
  • Paroxysmal cold hemoglobinuria (Donath-Landsteiner): Biphasic IgG.

Alloimmune

  • Transfusion reaction (ABO mismatch — intravascular; delayed — extravascular).
  • Hemolytic disease of fetus/newborn (Rh, Kell, etc.).

Drug-Induced

  • Penicillin/cephalosporins (hapten mechanism).
  • Methyldopa (autoantibody induction).
  • Immune checkpoint inhibitors (emerging).

Infection-Associated

  • Mycoplasma pneumoniae (cold agglutinins).
  • EBV, CMV, HIV, hepatitis.

Clinical Features

  • Anemia symptoms: fatigue, pallor, dyspnea, tachycardia.
  • Hemolysis signs: jaundice, dark urine, splenomegaly.
  • Acute: back pain, fever, hemoglobinuria (intravascular).

Diagnosis

  • DAT (Direct Antiglobulin Test / Coombs): Detects IgG/C3 on RBCs.
  • Reticulocytosis, ↑ LDH, ↑ indirect bilirubin, ↓ haptoglobin.
  • Peripheral smear: spherocytes (warm AIHA), agglutinates (cold).
  • Elution studies, antibody identification.

Treatment

  • Stop offending drug/treat infection.
  • Corticosteroids (1st line warm AIHA).
  • Rituximab (anti-CD20).
  • Splenectomy (refractory).
  • Transfusion (if symptomatic; least incompatible).
  • IVIG, complement inhibitors (sutimlimab for CAD).

Blood Disorders - Related Articles